| 1 |
Hayim Abrevaya |
Uop |
48 |
| 2 |
John MacLeod |
ExxonMobil |
17 |
| 3 |
Robert E. Dudley |
Clarus Therapeutics |
15 |
| #4 |
Klara Abravaya |
Abbott |
14 |
| #5 |
Drew Alexander Read Palin |
PepsiCo |
12 |
| #6 |
Peter Langmar |
Terk Technologies |
9 |
| #7 |
Charles S. Allen, Jr. |
Sloan Valve |
7 |
| #8 |
Michael De Giulio |
Kohler |
5 |
| #8 |
Kwang-Poo Chang |
Rosalind Franklin University Of Medicine And Science |
5 |
| #10 |
Peter John Robinson |
Cambridge Silicon Radio Limited |
4 |
| #10 |
David Bellamy |
Baxter Travenol Laboratories |
4 |
| #10 |
Donald J. Bainton |
Continental Ag |
4 |
| #13 |
John P. Hanley |
Ohaus Scale |
3 |
| #13 |
Tammy P. Mitchell |
Trans Union |
3 |
| #13 |
John P. Gnaedinger |
— |
3 |
| #16 |
Steven C. Evenstad |
— |
2 |
| #16 |
John E. Croghan |
— |
2 |
| #16 |
Anthony S. Zummer |
— |
2 |
| #16 |
Mark L. Cannon |
— |
2 |
| #16 |
Jennifer Koutouras |
— |
2 |
| #16 |
Kendra Christine Cunningham |
— |
2 |
| #16 |
Robert E. Drew |
— |
2 |
| #16 |
Peter Mark Mesrobian |
JPMorgan Chase |
2 |
| #16 |
Edward Allen Swabb |
G.D. Searle |
2 |
| #16 |
Scott R. Sargent |
— |
2 |
| #16 |
Matthew John Banholzer |
Mckinsey & Company |
2 |
| #16 |
Gregory S. Shearson |
Societe Des Produits Nestle S.A. |
2 |
| #28 |
W. Stephen Toan |
— |
1 |
| #28 |
Thomas J. Edson |
— |
1 |
| #28 |
Peter Burnett |
— |
1 |
| #28 |
Patrick J. Haynes, III |
— |
1 |
| #28 |
Roland Forsyth, III |
— |
1 |
| #28 |
Richard Boerke, Jr. |
Barclays Capital |
1 |
| #28 |
Melissa Stoller |
— |
1 |
| #28 |
Teresa Ciesielski |
— |
1 |
| #28 |
J. Jeffrey Geldermann |
— |
1 |
| #28 |
Michael R. de Guilio |
Kohler |
1 |
| #28 |
Eric Windeler |
— |
1 |
| #28 |
Katherine S. C. Denny |
— |
1 |
| #28 |
Henry A. Pickard |
— |
1 |
| #28 |
Talivaldis Cepuritis |
Johnson & Johnson |
1 |
| #28 |
Gerald F. Lahey |
Pullman Standard |
1 |
| #28 |
Gerald E. A. Perutz |
Nimlok |
1 |